12 Health Care Stocks Moving In Monday's After-Market Session

Loading...
Loading...

Gainers

  • Adaptimmune Therapeutics ADAP stock rose 12.7% to $1.6 during Monday's after-market session. The market value of their outstanding shares is at $258.9 million.
  • Epizyme EPZM shares rose 11.57% to $0.56. The market value of their outstanding shares is at $92.3 million. As per the news, the Q1 earnings report came out 4 days ago.
  • INVO Bioscience INVO stock rose 10.25% to $1.72. The market value of their outstanding shares is at $20.7 million. The company's, Q1 earnings came out today.
  • NantHealth NH shares increased by 10.11% to $0.65. The company's market cap stands at $75.0 million.
  • Adial Pharmaceuticals ADIL stock increased by 9.85% to $1.56. The company's market cap stands at $37.0 million. The company's, Q1 earnings came out today.
  • Revelation Biosciences REVB shares moved upwards by 8.66% to $0.74. The company's market cap stands at $11.1 million. As per the press release, Q1 earnings came out today.

Losers

  • NeuroOne Medical Tech NMTC shares decreased by 14.1% to $0.5 during Monday's after-market session. The company's market cap stands at $8.0 million. As per the news, the Q2 earnings report came out 2 days ago.
  • Femasys FEMY stock declined by 9.64% to $1.5. The company's market cap stands at $17.7 million. The company's, Q1 earnings came out 3 days ago.
  • Adamis Pharmaceuticals ADMP stock declined by 9.6% to $0.42. The market value of their outstanding shares is at $62.8 million. As per the news, the Q1 earnings report came out today.
  • Acer Therapeutics ACER stock decreased by 9.23% to $1.87. The company's market cap stands at $28.6 million. The company's, Q1 earnings came out today.
  • Aspira Womens Health AWH shares declined by 8.11% to $0.53. Trading volume for this security closed at 80.3K, accounting for 16.8% of its average full-day volume over the last 100 days. The company's market cap stands at $59.8 million. As per the news, the Q1 earnings report came out 3 days ago.
  • SCYNEXIS SCYX stock fell 7.66% to $1.93. The market value of their outstanding shares is at $56.3 million. The company's, Q1 earnings came out 2 days ago. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: MoversBZI-TFM
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...